... | @@ -45,7 +45,7 @@ In practice: |
... | @@ -45,7 +45,7 @@ In practice: |
|
|
|
|
|
We highly recommend that, when designing the datasets, features are as explicit as possible. A good way to start would be the metanodes defined in the Bioteque:
|
|
We highly recommend that, when designing the datasets, features are as explicit as possible. A good way to start would be the metanodes defined in the Bioteque:
|
|
|
|
|
|
|Node|Abbreviation|
|
|
|Metanode|Abbreviation|
|
|
|---|---|
|
|
|---|---|
|
|
|Assay|`ASY`|
|
|
|Assay|`ASY`|
|
|
|Cell|`CLL`|
|
|
|Cell|`CLL`|
|
... | @@ -56,7 +56,7 @@ We highly recommend that, when designing the datasets, features are as explicit |
... | @@ -56,7 +56,7 @@ We highly recommend that, when designing the datasets, features are as explicit |
|
|Gene/Protein|`GEN`|
|
|
|Gene/Protein|`GEN`|
|
|
|Disease|`DIS`|
|
|
|Disease|`DIS`|
|
|
|Molecular function|`MFN`|
|
|
|Molecular function|`MFN`|
|
|
|Pathway/processes|`PWY`|
|
|
|Pathway/process|`PWY`|
|
|
|Protein class|`PCL`|
|
|
|Protein class|`PCL`|
|
|
|Perturbagen|`PGN`|
|
|
|Perturbagen|`PGN`|
|
|
|Symptom|`SYM`|
|
|
|Symptom|`SYM`|
|
... | | ... | |